Within the YMC Group, ChromaCon AG is the center of excellence for developing and commercializing continuous chromatographic process technologies. ChromaCon AG is based in Switzerland, but has a global footprint. Our vision is to improve the efficiency of bioprocessing by providing best-in-class chromatography equipment to develop and manufacture the next-generation of chemical and biological medicines using continuous manufacturing technology. Continuous manufacturing offers 30-50% reduction in CAPEX and OPEX compared to conventional batch manufacturing. We are unique in providing a twin-column FPLC development system, the Contichrom CUBE, for the continuous purification of peptides, oligonucleotides, mAbs, and small molecules. The Contichrom CUBE has multiple process capabilities allowing our customers to choose the best purification process for any given purification challenge: MCSGP – Continuous preparative chromatography with automated side-cut recycling CaptureSMB – Continuous capture chromatography for maximum resin utilization N-Rich – Automated enrichment and purification of impurities ChromaCon has a full range of process and process control patents and offer, together with our scale-up partner, YMC America, a one-stop solution from laboratory to GMP process scale.